Vasculitis in elderly. About two clinical cases and literature review
PDF (Español (España))
HTML (Español (España))
PDF

Supplementary Files

Carta de presentación (Español (España))

Keywords

ANCA
vasculitis
elderly
microscopic polyangiitis
glomerular disease
renal impairment.

How to Cite

1.
Pillajo Sánchez BL, Sanango W, Osorio W. Vasculitis in elderly. About two clinical cases and literature review. Rev. Colomb. Nefrol. [Internet]. 2019 Mar. 1 [cited 2021 Dec. 3];6(1):57-62. Available from: http://www.revistanefrologia.org/index.php/rcn/article/view/314

Abstract

Currently we live a process of transition in the population pyramid. Therefore, kidney diseases become more frequent in the elderly. Thus, primary vasculitis in older adults are rare diseases, caused by the inflammation of blood vessels and poorly diagnosed. The literature is limited to few clinical cases. Cytoplasmic anti-neutrophil antibody (ANCA) positive vasculitis (AAV) is more common in people older than 50 years. The detection of ANCA gives a very poor prognosis in this population. Also, high suspicion and timely diagnosis is important, as this can provide optimal treatment and reduce the complications of the disease and those associated with immunosuppression. Older adults with AAV have greater renal involvement, hypertension, dyslipidemia and increased mortality. Therefore, two clinical cases from the date of diagnosis, age, laboratory values of the initial presentation and the scale of activity of Birmingham vasculitis confirmed with renal biopsy (ANCA positive) identified in a specialty hospital of Ecuador are detailed below.
https://doi.org/10.22265/acnef.6.1.314
PDF (Español (España))
HTML (Español (España))
PDF

References

1. Okazaki T, Shoshi Shinagawa, Hidenori Mikage. Vasculitis syndrome diagnosis and therapy. J Gen Fam Med. 2017;18(2):72–78. https://doi.org/10.1002/jgf2.4

2. Watts RA, Mahr A, Mohammad AJ, Gatenby P, Basu N, Flores-Suárez LF: Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Nephrol Dial Transplant. 2015;30(suppl 1):i14–i22. https://doi.org/10.1093/ndt/gfv022

3. Jennette J, Patrick Nachman. ANCA Glomerulonephritis and Vasculitis. Clin J Am Soc Nephrol. 2017;12(10):1680-1691. https://doi.org/10.2215/CJN.02500317

4. Watts R, Lane S. Epidemiology of systemic vasculitis. A ten-Year Study in the United Kingdom. Am Coll Rheumatology. 2000;43(2).

5. McNicholas BA, Griffin TP, Donnellan S, Ryan L, Garrahy A, Coughlan R, et al. ANCA-associated vasculitis: a comparision of cases presenting to nephrology and rheumatology services. QJM: An International Journal of Medicine. 2016; 109(12):803-809. https://doi.org/10.1093/qjmed/hcw100

6. Tarzi RM, Pusey CD. Vasculitis: Risks and rewards of treating elderly patients with vasculitis. Nat Rev Nephrol. 2011; 7(5): 253-55. https://doi.org/10.1038/nrneph.2011.30

7. Gallardo M, Scolnik M, Pompermayer LE, Scaglioni V, Soriano ER. Elderly Versus Younger Patients with ANCA-Associated Vasculitis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/elderly-versus-younger-patients-with-anca- associated-vasculitis/. Accessed June 20, 2018.
No national or foreign publication may partially or totally reproduce or translate Revista Colombiana de Nefrología articles or abstracts without prior written permission from the journal’s Editorial Board.

Downloads

Download data is not yet available.